Effect of antimalarials treatment on rat liver lysosomal function—Anin vivo study
Tóm tắt
Effects of treatmentin vivo with the antimalarials:chloroquine (CQ), primaquine (PQ) and quinine(Q) on lysosomal enzymes and lysosomal membrane integrity were examined. Treatment with the three antimalarials showed an apparent increase in the membrane stability. CQ treatment resulted in increase in both the ‘free’ and ‘total’ activities of all the enzymes i.e. acid phosphatase, RNase II, DNase II and cathepsin D. PQ treatment lowered the ‘free’ and ‘total’ activities of acid phosphatase and cathepsin D, but the DNase II activities increased. Treatment with Q resulted in increased ‘free’ and ‘total’ activities of RNase II and DNase II. While ‘free’ activities of acid phosphatase and cathepsin D were low; the ‘total’ activities increased significantly. Our results suggest that a generalized increase in free nucleases activities following prolonged treatment with antimalarials may lead to cell damage and/or necrosis.
Tài liệu tham khảo
Leslie, T.W. Jr (1990) Drugs used in the chemotherapy of protozoal infections- Malaria. InThe pharmacological basis of therapeutics, (Gilmann, A.G., Rall, T.W., Nies, A.S. and Taylor, P Eds) 8th ed, pp 959–997, Pergamon press, New York.
Foley, M. and Tilley, L. (1998). Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol. Ther. 79(1), 55–87.
Deepalakshmi, P.D., Parasakthy, K. and Shanti, S. (1994). Devrajan NS, Effect of chloroquine on rat liver mitochondria, Ind. J. Exp. Biol. 32, 797–801.
Essien, E.E. and Ette, E.I. (1986). Effects of chloroquine and didesethylchloroquine on rabbit myocardium and mitochondria. J. Pharm. Pharmacol. 38(7), 543–546
Jarzyna, R., Lenarcik, E. and Bryla, J. (1997). Chloroquine is a potent inhibitor of glutamate dehydrogenase in liver and kidney-cortex of rabbit. Pharmacol. Res. 35(1), 79–84.
Magware, T., Naik, Y.S. and Haslem, J.A. (1997a). Effects of chloroquine treatment on antioxident enzymes in rat liver and kidney, Free Rad. Biol. & Med. 22, 321–325.
Magware, T., Naik, Y.S. and Haslem, J.A. (1997b). Primaquine alters antioxidant enzyme profiles in rat liver and kidney, Free Rad. Res. 27, 173–176.
de Duve, C., de Barsy, T., Poole, B., Trouet, A., Tulkens, P. and Van Hoof, F. (1974). Lysosomotropic agents, Biochem. Pharmacol. 23, 2495–2568.
Hostetler, K.Y., Reasor, M. and Yazaki, P.J. (1985). Chloroquine-induced phospholipid fatty liver. Measurement of drug and lipid concentrations in rat liver lysosomes. J. Biol. Chem. 260(1), 215–219.
Patel, B.D. (2004), Pandya, J.D., Katewa, S.D. and Katyare, S.S. Effect of antimalarials on rat liver lysosomes: anin vitro study, J. Anim. Morph. Physiol. 50 (In Press).
Thabrew, M.I., Nashiru, T.O. and Emerole, G.O. (1985). Drug induced alterations in some rat hepatic microsomal components: a comparative study of four structurally different antimalarials. Comp. Biochem. Physiol. C. 81(1), 133–138.
Barrett, A.J. and Heath, M.F. (1977). Lysosomal enzymes, inLysosomes: a laboratory handbook, (Dingle, J.T Ed), 2nd ed, pp. 20–145, Elsevier/ North-Holand Biomedical Press, Amsterdam.
Gianetto, R. and de Duve, C. (1955). Preparation of rat liver lysosomes. Biochem. J. 59, 433–437.
Satav, J.G. and Katyare, S.S. (1981). Thyroid hormones and cathepsin D activity in rat liver, kidney and brain, Experintia. 37, 100–101.
Nerurkar, M.A., Satav, J.G. and Katyare, S.S. (1988). Insulin dependent changes in lysosomal cathepsin D activity in rat liver, kidney, brain and heart, Diabetalogia 31, 119–123.
Fiske, C.H. and Subba Row, Y. (1925) Colorimetric determination of phosphorus, J. Biol. Chem. 66, 375–381.
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951). Protein measurement with Folin-phenol reagent, J. Biol. Chem. 193, 265–272.
Korolenko, T.A., Rukavishnikova, E.V., Safina, A.F., Mynkina, G.I. and Vereshchagin, E.I. (1991). Effects of chloroquine on lysosomes and endocytosis by liver cells in vivo. Acta Biol. Hung. 42(1–3), 301–309.
Khandkar, M.A., Parmar, D.V., Das, M. and Katyare, S.S. (1996). Is activation of lysosomal enzymes responsible for paracetamol induced hepatotoxicity and nephrototoxicity, J. Pharm. Pharmacol. 48, 437–441.
Vermeulen, N.P.E., Bessems, J.G.M. and Van De Straat, R. (1992). Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism based prevention. Drug Metab. Rev. 24, 367–407.
Acharya, M.A., Khamesra S.H. and Katyare, S.S. (2004) Effect of repeated intraperitoneal exposure to picrotoxin on rat liver lysosomal function. Ind. J. Expt. Biol. 42, 808–811.
Acharya, M.M., Khamesra, S.H. and Katyare, S.S. (2004) Picrotoxin-induced convulsions and lysosomal function in the rat brain. Ind. J. Clin. Biochem. (In Press).
Zola-Morgan S., Squire L.R. and Amaral D.G. (1986a). Human amnesia and the medical temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neuroscience, 6, 2950–2967.
Zola-Morgan S., Squire L.R., Rempel, N.L. and Amaral D.G., (1992 b) Enduring memory impairment in monkeys after ischemic damage to the hippocampus. J. Neuroscience, 12, 2582–2595.
Szego M.C. and Pietras J.R. (1984) Lysosomal functions in cellular activation: Propogation of the actions of Hormones and other effectors. Int. Rev. Cytol. 88, 1–341.
Pandya, J.D., Patel, B.D., Katewa, S.D. and Katyare, S.S. (2003) Studies on kinetic properties of acid phosphatase from nuclei—free rat liver homogenate using, different substrates. Ind. J. Exp. Biol. 41, 205–210
Katewa, S.D. and Katyare S.S. (2004) Treatment with anti-malarials adversely affects the oxidative energy metabolism in rat liver mitochondria. Drug and Chem. Toxicol. 27(1), 1–13.